Quest Diagnostics Incorporated (DGX)
| Market Cap | 15.88B |
| Revenue (ttm) | 10.34B |
| Net Income (ttm) | 1.80B |
| Shares Out | 133.00M |
| EPS (ttm) | 13.18 |
| PE Ratio | 9.88 |
| Forward PE | 11.29 |
| Dividend | $2.30 |
| Dividend Yield | 1.77% |
| Trading Day | June 22 |
| Last Price | $130.24 |
| Previous Close | $129.43 |
| Change ($) | 0.81 |
| Change (%) | 0.63% |
| Day's Open | 129.57 |
| Day's Range | 129.51 - 130.88 |
| Day's Volume | 1,096,866 |
| 52-Week Range | 101.78 - 142.80 |
SECAUCUS, N.J., June 21, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released the Annual Corporate Responsibil...
When screening the market for high return investments amid non-cyclical stocks, investors may want to consider the three companies listed below, as their earnings yields (as calculated via Joel Greenbla...
These companies dominate a vital medical industry niche, and their valuations are near their all-time lows.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today launched the EZH2Now...
MedTech testing stocks like Quest Diagnostics Incorporated (DGX), Thermo Fisher Scientific, Inc. (TMO) and Laboratory Corporation of America Holdings (LH) are likely to survive post-pandemic.
3 Medical Info System Stocks to Bank on Despite Decline in COVID-19 Cases
Mercy's outreach laboratory services are set to get integrated into Quest Diagnostics' (DGX) full-service laboratory in Lenexa, KS.
SECAUCUS, N.J. and ST. LOUIS, June 1, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX) and Mercy today announced that Quest has completed its previously announced acquisition of the outreach laboratory...
Quest Diagnostics' (DGX) new collaboration with SAHRC will help improve the health and quality of lives of underserved communities.
SECAUCUS, N.J., May 26, 2021 /PRNewswire/ -- The COVID-19 pandemic did not dampen workforce drug testing positivity for marijuana, which continued to increase last year in the general U.S. workforce, ac...
Like many other diagnostics and drug development companies, Laboratory Corp. of America Holdings ( LH , Financial) saw its base business decline as Covid-19 took hold. Fewer patients sought routine medi...
3 Stocks to Bank on Rebounding Outpatient Home Health Industry
Contributions from acquisitions and Professional Lab Services relationships accelerate base business growth for Quest Diagnostics (DGX).
SECAUCUS, N.J. and NEW YORK, May 25, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX) and Paige today announced a collaboration designed to unlock the potential of artificial intelligence (AI) to impro...
SAN ANTONIO and SECAUCUS, N.J., May 24, 2021 /PRNewswire/ -- Childhood obesity has disproportionately affected Hispanic and Black communities as a result of negative social determinants of health for ye...
SECAUCUS, N.J., May 20, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarte...
SECAUCUS, N.J., May 19, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the J...
If you are looking for bargain opportunities among U.S.-listed equities, then you may want to consider the following three stocks, as they meet the criteria just listed below:
This zero out-of-pocket option applies to Quest Diagnostics' (DGX) molecular laboratory (PCR/NAAT) as well as rapid antigen testing.
SECAUCUS, N.J., May 11, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled several new enhancements to its COVID-19 testi...
SECAUCUS, N.J., May 11, 2021 /PRNewswire/ -- A new Quest Diagnostics Health Trends® report developed in collaboration with the Centers for Disease Control and Prevention (CDC) found that the COVID-19 p...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--CIC Health and Quest Diagnostics announced a collaboration that will help more schools safely return to in-person learning.
Ginkgo Bioworks Teams with Quest Diagnostics to Provide COVID-19 Testing for K-12 Schools Nationwide
BOSTON, May 3, 2021 /PRNewswire/ -- Ginkgo Bioworks ("Ginkgo") today announced a collaboration with Quest Diagnostics (NYSE:DGX) to provide COVID-19 Kindergarten through Senior (K-12) school testing se...
SECAUCUS, N.J., April 27, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the...
The updated first-half 2021 outlook by Quest Diagnostics (DGX) looks impressive given its raised revenue and operating cash flow expectations.
Quest Diagnostics (DGX) delivered earnings and revenue surprises of -0.27% and 1.29%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Quest Diagnostics (NYSE:DGX) rose 0.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 300.00% year over year to $3.76, which beat t...
SECAUCUS, N.J., April 22, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the firs...
Through the first quarter, Quest Diagnostics' (DGX) several significant strides in the field of COVID-19 diagnostic testing are expected to have contributed to the top line.
SECAUCUS, N.J. and HELSINKI, Finland, April 13, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Blueprint Genetics announced toda...
As of April 9, the GuruFocus All-in-One Screener, a Premium feature, found that the following companies have low price-earnings ratios and high dividend yields.
SECAUCUS, N.J., April 7, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 202...
Quest Diagnostics (DGX) enters into an agreement with the CDC to provide genomic sequencing to identify new mutations in and patterns of transmission of SARS-CoV-2.
Quest Diagnostics' (DGX) divestment of Q2 solutions to IQVIA will allow IQVIA to lead Q2 Solutions on the next stage of its journey in central lab services as a global leader.
Quest Diagnostics Inc (NYSE: DGX) has announced selling the minority share in Q2 Solutions to IQVIA Holdings Inc (NYSE: IQV) for $760 million in cash. Q2 Solutions provides comprehensive testing, projec...
Investors are optimistic about Quest Diagnostics (DGX) owing to strong demand for COVID-19 testing and well-positioned growth strategy.
SECAUCUS, N.J. and RESEARCH TRIANGLE PARK, N.C.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research ser...
Value investors may be interested in the following three stocks since their share prices are trading below their respective Peter Lynch earnings lines, indicating they could be undervalued. Sell-side an...
Quest Diagnostics (DGX) signs agreement with Zora to develop cardiovascular mortality prediction test with the help of the latter's patented ceramide-analysis technology.
SECAUCUS, N.J. and HELSINKI, March 15, 2021 /PRNewswire/ -- Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughp...
SECAUCUS, N.J., March 11, 2021 /PRNewswire/ -- At a virtual meeting with analysts and investors at its Investor Day, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), ...
SECAUCUS, N.J., and ST. LOUIS, March 8, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation's most highly integrated...
Davis Select Advisors recently released its fourth-quarter 2020 portfolio update. Among the changes made during the quarter, the firm disclosed a new position in Viatris Inc. (NASDAQ:VTRS), a position b...
About DGX
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent ... [Read more...]
| Industry Diagnostics & Research | IPO Date Dec 17, 1996 |
| CEO Stephen Rusckowski | Employees 50,000 |
| Stock Exchange NYSE | Ticker Symbol DGX |
Financial Performance
In 2020, DGX's revenue was $9.44 billion, an increase of 22.15% compared to the previous year's $7.73 billion. Earnings were $1.43 billion, an increase of 66.78%.
Analyst Forecasts
According to 18 analysts, the average rating for DGX stock is "Buy." The 12-month stock price forecast is 145.21, which is an increase of 11.49% from the latest price.